240 related articles for article (PubMed ID: 22885424)
1. Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis.
Pereira RM; Carvalho JF; Paula AP; Zerbini C; Domiciano DS; Gonçalves H; Danowski JS; Marques Neto JF; Mendonça LM; Bezerra MC; Terreri MT; Imamura M; Weingrill P; Plapler PG; Radominski S; Tourinho T; Szejnfeld VL; Andrada NC; ; ;
Rev Bras Reumatol; 2012 Aug; 52(4):580-93. PubMed ID: 22885424
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: an update of Brazilian Society of Rheumatology (2020).
Pereira RMR; Perez MO; Paula AP; Moreira C; Castro CHM; Zerbini CAF; Domiciano DS; de Azevedo E; Mendonca LMC; Shinzato MM; da Rocha-Loures MAA; Radominski S; Szejnfeld VL
Arch Osteoporos; 2021 Mar; 16(1):49. PubMed ID: 33646403
[TBL] [Abstract][Full Text] [Related]
3. Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update : This manuscript has been produced under the auspices of the Committee of National Societies (CNS) and the Committee of Scientific Advisors (CSA) of the International Osteoporosis Foundation (IOF).
Messina OD; Vidal M; Torres JAM; Vidal LF; Arguissain C; Pereira RM; Clark P; Cerdas Perez S; Campusano C; Lazaretti-Castro M; Zerbini C; Scali JJ; Mendez Sanchez L; Peralta-Pedrero ML; Cavallo A; Valdivia Ibarra FJ; Hernandez Pérez T
Aging Clin Exp Res; 2022 Nov; 34(11):2591-2602. PubMed ID: 36348222
[TBL] [Abstract][Full Text] [Related]
4. Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.
Laurent MR; Goemaere S; Verroken C; Bergmann P; Body JJ; Bruyère O; Cavalier E; Rozenberg S; Lapauw B; Gielen E
Front Endocrinol (Lausanne); 2022; 13():908727. PubMed ID: 35757436
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care?
Sapkota S; Baig S; Hess T; O'Connell AM; Menk J; Shyne M; Fazeli P; Ensrud K; Shmagel A
Lupus; 2020 Mar; 29(3):263-272. PubMed ID: 31996109
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid induced osteoporosis.
Hu K; Adachi JD
Expert Rev Endocrinol Metab; 2019 Jul; 14(4):259-266. PubMed ID: 31094232
[TBL] [Abstract][Full Text] [Related]
7. Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis.
Raterman HG; Bultink IEM; Lems WF
Drugs; 2019 Jul; 79(10):1065-1087. PubMed ID: 31201710
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid-Induced Osteoporosis: Why Kids Are Different.
Ward LM
Front Endocrinol (Lausanne); 2020; 11():576. PubMed ID: 33391179
[TBL] [Abstract][Full Text] [Related]
9. German Society of Rheumatology recommendations for management of glucocorticoid-induced osteoporosis.
Leipe J; Holle JU; Weseloh C; Pfeil A; Krüger K
Z Rheumatol; 2021 Dec; 80(Suppl 2):49-63. PubMed ID: 34705070
[TBL] [Abstract][Full Text] [Related]
10. [German Society of Rheumatology Recommendations for the management of glucocorticoid-induced Osteoporosis. German version].
Leipe J; Holle JU; Weseloh C; Pfeil A; Krüger K;
Z Rheumatol; 2021 Sep; 80(7):670-687. PubMed ID: 34357436
[TBL] [Abstract][Full Text] [Related]
11. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
Humphrey MB; Russell L; Danila MI; Fink HA; Guyatt G; Cannon M; Caplan L; Gore S; Grossman J; Hansen KE; Lane NE; Ma NS; Magrey M; McAlindon T; Robinson AB; Saha S; Womack C; Abdulhadi B; Charles JF; Cheah JTL; Chou S; Goyal I; Haseltine K; Jackson L; Mirza R; Moledina I; Punni E; Rinden T; Turgunbaev M; Wysham K; Turner AS; Uhl S
Arthritis Rheumatol; 2023 Dec; 75(12):2088-2102. PubMed ID: 37845798
[TBL] [Abstract][Full Text] [Related]
12. Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis.
Chiodini I; Falchetti A; Merlotti D; Eller Vainicher C; Gennari L
Expert Rev Endocrinol Metab; 2020 Jul; 15(4):283-298. PubMed ID: 32584619
[TBL] [Abstract][Full Text] [Related]
13. Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial.
Saag KG; Pannacciulli N; Geusens P; Adachi JD; Messina OD; Morales-Torres J; Emkey R; Butler PW; Yin X; Lems WF
Arthritis Rheumatol; 2019 Jul; 71(7):1174-1184. PubMed ID: 30816640
[TBL] [Abstract][Full Text] [Related]
14. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE.
Camacho PM; Petak SM; Binkley N; Diab DL; Eldeiry LS; Farooki A; Harris ST; Hurley DL; Kelly J; Lewiecki EM; Pessah-Pollack R; McClung M; Wimalawansa SJ; Watts NB
Endocr Pract; 2020 May; 26(Suppl 1):1-46. PubMed ID: 32427503
[No Abstract] [Full Text] [Related]
15. Guideline adherence by physicians for management of glucocorticoid-induced osteoporosis in Japan: a nationwide health insurance claims database study.
Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
Osteoporos Int; 2022 May; 33(5):1097-1108. PubMed ID: 35022812
[TBL] [Abstract][Full Text] [Related]
16. The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis.
Tanaka Y; Soen S; Hirata S; Okada Y; Fujiwara S; Tanaka I; Kitajima Y; Kubota T; Ebina K; Takashi Y; Inoue R; Yamauchi M; Okubo N; Ueno M; Ohata Y; Ito N; Ozono K; Nakayama H; Terauchi M; Tanaka S; Fukumoto S
J Bone Miner Metab; 2024 Mar; 42(2):143-154. PubMed ID: 38538869
[TBL] [Abstract][Full Text] [Related]
17. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.
Humphrey MB; Russell L; Danila MI; Fink HA; Guyatt G; Cannon M; Caplan L; Gore S; Grossman J; Hansen KE; Lane NE; Ma NS; Magrey M; McAlindon T; Robinson AB; Saha S; Womack C; Abdulhadi B; Charles JF; Cheah JTL; Chou S; Goyal I; Haseltine K; Jackson L; Mirza R; Moledina I; Punni E; Rinden T; Turgunbaev M; Wysham K; Turner AS; Uhl S
Arthritis Care Res (Hoboken); 2023 Dec; 75(12):2405-2419. PubMed ID: 37884467
[TBL] [Abstract][Full Text] [Related]
18. Pharmacist-initiated interventions to test quantitative bone mineral density and prescribe osteoporosis medications to prevent steroid-induced osteoporosis.
Hirose T; Mori K; Kimura M; Yamashita S; Hayashi H; Usami E; Tanase T
Pharmazie; 2024 Jun; 79(6):124-128. PubMed ID: 38877679
[TBL] [Abstract][Full Text] [Related]
19. The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice.
Walker-Bone K; Wood A; Hull R; Ledingham JM; McCrae FC; Shaban R; Thomas A; Mackay K
Clin Med (Lond); 2004; 4(5):431-6. PubMed ID: 15536872
[TBL] [Abstract][Full Text] [Related]
20. GLUCOCORTICOID-INDUCED BONE DISEASE: MECHANISMS AND IMPORTANCE IN PEDIATRIC PRACTICE.
Sarinho ESC; Melo VMPP
Rev Paul Pediatr; 2017; 35(2):207-215. PubMed ID: 28977339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
